2026年全球組織診斷市場報告

近年來，組織診斷市場發展迅速，預計將從2025年的63.8億美元成長到2026年的72.5億美元，複合年成長率達13.6%。過去幾年的成長可歸因於多種因素，例如癌症診斷數量的增加、醫院病理檢查室的擴建、免疫組織化學技術的日益普及、自動化診斷設備的廣泛應用以及先進試劑的供應改善。

預計未來幾年組織診斷市場將快速成長，到2030年市場規模將達到119.7億美元，複合年成長率（CAGR）為13.4%。預測期內的成長可歸因於對精準診斷需求的不斷成長、人工智慧輔助病理工具的日益普及、個人化醫療舉措的擴展、對數位醫療基礎設施投資的增加，以及對診斷準確性和周轉時間的日益重視。預測期內的關鍵趨勢包括：數位病理平台的日益普及、自動化組織染色系統的使用日益增多、基於人工智慧的影像分析的更深入整合、多重組織檢測的擴展以及對工作流程標準化的日益重視。

預計未來幾年，癌症發生率的不斷上升將推動組織診斷市場的成長。癌症是由於基因改變導致細胞不受控制地生長，破壞身體組織並形成稱為腫瘤的腫塊而引起的。腫瘤可分為惡性腫瘤（癌性腫瘤）及良性腫瘤（良性腫瘤）。包括基因突變、致癌物質、吸煙、肥胖、輻射和激素在內的多種因素都可能導致癌症的發生。隨著癌症病例的增加，對組織診斷等檢測方法的需求也將隨之成長，這些方法對於確定疾病的進展至關重要。例如，總部位於瑞士的聯合國機構－世界衛生組織（WHO）在2024年2月預測，2050年，新增癌症病例數將從2022年的約2,000萬例增加77%，超過3,500萬例。因此，癌症發生率的上升正在推動組織診斷市場的擴張。

技術進步，尤其是人工智慧（AI）的整合應用，正在影響組織診斷市場。人工智慧被用於分析醫學影像和病理數據，從而提高疾病檢測和分類的準確性和效率。例如，Qritive公司於2023年推出了Qai Prostate，這是一款基於人工智慧的前列腺癌檢測工具，能夠幫助病理學家更有效地檢測和分類切片檢查組織樣本中的良性和惡性腫瘤部位。人工智慧的這種融合應用可以被視為組織診斷市場提高癌症診斷和治療準確性的策略性舉措。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球組織診斷市場：吸引力評分與分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 人工智慧（AI）和自主人工智慧
  • 生物技術、基因組學和精準醫學
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
  • 物聯網、智慧基礎設施、互聯生態系統
• 主要趨勢
  • 數位病理平台的應用日益廣泛
  • 自動化組織染色系統的廣泛應用
  • 基於人工智慧的影像分析技術的整合正在不斷推進。
  • 擴展多重組織偵測
  • 越來越重視工作流程標準化

第5章 終端用戶產業市場分析

• 醫院
• 研究所
• 製藥公司
• CRO（受託研究機構）
• 診斷檢查室

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球組織診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 全球組織診斷市場規模、對比及成長率分析
• 全球組織診斷市場表現：規模與成長，2020-2025年
• 全球組織診斷市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球總潛在市場（TAM）

第9章 市場細分

• 依產品
• 耗材、抗體、試劑盒、試劑、探針、設備、玻片染色系統、掃描器、組織處理系統
• 透過技術
• 免疫組織化學（IHC）、原位雜合反應（ISH）、數位病理學和工作流程管理、特殊染色
• 因疾病
• 乳癌、胃癌、淋巴瘤、攝護腺癌、非小細胞肺癌（NSCLC）
• 最終用戶
• 醫院、研究機構、製藥公司、受託研究機構
• 按類型細分：消耗品
• 切片穿刺針、玻片和蓋玻片、組織包埋材料
• 按類型細分：抗體
• 一抗、二抗、單株抗體、多株抗體
• 按類型細分：套裝
• 診斷試劑盒、檢測試劑盒、染色試劑盒
• 按類型細分：試劑
• 固定劑、染色劑、抗原修復液
• 按類型細分：探針
• 螢光探針、分子探針、雜合反應探針
• 按類型細分：設備
• 顯微鏡、組織微陣列裝置、雷射捕捉晶粒裝置
• 按類型細分：載玻片染色系統
• 自動染色設備，手動染色系統
• 按類型細分：掃描儀
• 數位載玻片掃描儀，全載玻片成像系統
• 按類型細分：組織處理系統
• 組織處理設備、包埋中心、切片機

第10章 區域與國家分析

• 全球組織診斷市場：區域分析、預測與趨勢，2020-2025年、2025-2030年預測、2035年預測
• 全球組織診斷市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 組織診斷市場：競爭格局與市場佔有率，2024 年
• 組織診斷市場：企業評估矩陣
• 組織診斷市場：公司概況
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Agilent Technologies Inc.

第37章：其他領先和創新企業

• Merck KGaA, BioGenex Laboratories, Sakura Finetek Co. Ltd., Philips Healthcare NV, Bio-Rad Laboratories, Ventana Medical Systems Inc., Hologic Inc., Becton Dickinson and Company, Sysmex Corporation, Cell Signaling Technology Inc., Enzo Life Sciences Inc., Leica Microsystems GmbH, Menarini Diagnostics Srl, PerkinElmer Inc., QIAGEN NV

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年組織診斷市場：提供新機會的國家
• 2030年組織診斷市場：新興細分市場機會
• 2030年組織診斷市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Tissue diagnostic refers to a medical procedure that uses instruments to remove and stain tissue that must be sent to a laboratory or pathology department for documentation of what was excised for patient care (for tissue diagnostics). This offers measurements and descriptions, including any abnormalities, and an interpretation (or diagnosis) of health or disease status, under applicable legislation.

The main types of products in tissue diagnostic are consumables, antibodies, kits, reagents, probes, instrument, slide staining system, scanner and tissue processing system. The antibodies are used for the detection of infections, recognition of allergies, and the measurement of hormones and other biological markers in the blood in tissue diagnostics. The technologies used in tissue diagnostic are immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and workflow management and special staining to detect diseases such as breast cancer, gastric cancer, lymphoma, prostate cancer and non-small cell lung cancer (NSCLC). Tissue diagnostic is mostly used in hospitals, research laboratories, pharmaceutical companies, and contract research organizations.

Tariffs are impacting the tissue diagnostic market by increasing costs of imported antibodies, reagents, scanners, microscopes, and automated staining systems used in pathology laboratories. Hospitals and research laboratories in North America and Europe are most affected due to dependence on imported high-value diagnostic equipment, while Asia-Pacific faces pricing pressure on consumables and imaging systems. These tariffs are raising laboratory operating costs and slowing equipment upgrades. However, they are also encouraging local manufacturing of diagnostic reagents, regional assembly of instruments, and greater investment in domestic diagnostic technology capabilities.

The tissue diagnostic market research report is one of a series of new reports from The Business Research Company that provides tissue diagnostic market statistics, including tissue diagnostic industry global market size, regional shares, competitors with a tissue diagnostic market share, detailed tissue diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the tissue diagnostic industry. This tissue diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tissue diagnostic market size has grown rapidly in recent years. It will grow from $6.38 billion in 2025 to $7.25 billion in 2026 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to increasing cancer diagnostic volumes, expansion of hospital pathology laboratories, growing adoption of immunohistochemistry techniques, rising use of automated diagnostic instruments, increased availability of advanced reagents.

The tissue diagnostic market size is expected to see rapid growth in the next few years. It will grow to $11.97 billion in 2030 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to increasing demand for precision diagnostics, rising adoption of ai-assisted pathology tools, expansion of personalized medicine initiatives, growing investments in digital healthcare infrastructure, increasing focus on diagnostic accuracy and turnaround time. Major trends in the forecast period include increasing adoption of digital pathology platforms, rising use of automated tissue staining systems, growing integration of ai-based image analysis, expansion of multiplex tissue assays, enhanced focus on workflow standardization.

The increasing incidence of cancer is expected to drive the growth of the tissue diagnostic market in the coming years. Cancer begins when genetic changes cause cells to grow uncontrollably, destroying body tissue and forming a mass known as a tumor, which can be either cancerous or benign. Various factors, including genetic mutations, carcinogens, smoking, obesity, radiation, and hormones, can lead to the development of cancer. As cancer cases rise, the demand for diagnostic procedures like tissue diagnostics will grow, as these are essential in determining the disease's progression. For example, in February 2024, the World Health Organization, a Switzerland-based United Nations agency, projected that new cancer cases would rise to over 35 million by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Thus, the rising cancer incidence is fueling the expansion of the tissue diagnostic market.

The technological advancements, particularly the integration of artificial intelligence (AI), are influencing the tissue diagnostic market. AI is employed to analyze medical images and pathological data, enhancing the accuracy and efficiency of disease detection and classification. For instance, in 2023, Qritive introduced the Qai Prostate, an AI-powered prostate cancer detection tool, providing pathologists with advanced capabilities for detecting and classifying malignant and benign tumor locations in biopsy tissue samples. This integration of AI represents a strategic move to improve precision in cancer diagnosis and treatment within the tissue diagnostic market.

In February 2024, F. Hoffmann-La Roche AG, a Switzerland-based healthcare technology company, entered into a partnership with PathAI Inc. Through this collaboration, Roche and PathAI seek to strengthen digital pathology capabilities by embedding artificial intelligence-driven image analysis into Roche's pathology workflows, thereby accelerating diagnostic insights and enhancing support for research activities and clinical decision-making. PathAI Inc., a United States-based technology company, focuses on developing artificial intelligence and machine learning solutions for pathology with the objective of improving diagnostic accuracy, operational efficiency, and scalability in disease detection and analysis.

Major companies operating in the tissue diagnostic market are F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies Inc., Merck KGaA, BioGenex Laboratories, Sakura Finetek Co. Ltd., Philips Healthcare NV, Bio-Rad Laboratories, Ventana Medical Systems Inc., Hologic Inc., Becton Dickinson and Company, Sysmex Corporation, Cell Signaling Technology Inc., Enzo Life Sciences Inc., Leica Microsystems GmbH, Menarini Diagnostics S.r.l, PerkinElmer Inc., QIAGEN N.V., Siemens Healthineers AG, Zeiss Group AG

North America was the largest region in the tissue diagnostic market in 2025. The regions covered in the tissue diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tissue diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tissue diagnostic market includes revenues earned by entities by consumables and instruments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Diagnostic Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses tissue diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tissue diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Consumables; Antibodies; Kits; Reagents; Probes; Instruments; Slide Staining System; Scanner; Tissue Processing system
• 2) By Technology: Immunohistochemistry (IHC); In Situ Hybridization (ISH); Digital Pathology And Workflow Management; Special Staining
• 3) By Disease: Breast Cancer; Gastric Cancer; Lymphoma; Prostate Cancer; Non-Small Cell Lung Cancer (NSCLC)
• 4) By End User: Hospitals; Research Laboratories; Pharmaceutical Companies; Contract Research Organizations
• Subsegments:
• 1) By Consumables: Biopsy Needles; Slides And Cover Slips; Tissue Embedding Materials
• 2) By Antibodies: Primary Antibodies; Secondary Antibodies; Monoclonal Antibodies; Polyclonal Antibodies
• 3) By Kits: Diagnostic Kits; Assay Kits; Staining Kits
• 4) By Reagents: Fixatives; Staining Reagents; Antigen Retrieval Solutions
• 5) By Probes: Fluorescent Probes; Molecular Probes; Hybridization Probes
• 6) By Instruments: Microscopes; Tissue Microarray Instruments; Laser Capture Microdissection Instruments
• 7) By Slide Staining System: Automated Stainers; Manual Staining Systems
• 8) By Scanner: Digital Slide Scanners; Whole Slide Imaging Systems
• 9) By Tissue Processing System: Tissue Processors; Embedding Centers; Microtomes
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Danaher Corporation; Thermo Fisher Scientific Inc.; Abbott Laboratories; Agilent Technologies Inc.; Merck KGaA; BioGenex Laboratories; Sakura Finetek Co. Ltd.; Philips Healthcare NV; Bio-Rad Laboratories; Ventana Medical Systems Inc.; Hologic Inc.; Becton Dickinson and Company; Sysmex Corporation; Cell Signaling Technology Inc.; Enzo Life Sciences Inc.; Leica Microsystems GmbH; Menarini Diagnostics S.r.l; PerkinElmer Inc.; QIAGEN N.V.; Siemens Healthineers AG; Zeiss Group AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Tissue Diagnostic Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Tissue Diagnostic Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Tissue Diagnostic Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Tissue Diagnostic Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Digital Pathology Platforms
  • 4.2.2 Rising Use Of Automated Tissue Staining Systems
  • 4.2.3 Growing Integration Of Ai-Based Image Analysis
  • 4.2.4 Expansion Of Multiplex Tissue Assays
  • 4.2.5 Enhanced Focus On Workflow Standardization

5. Tissue Diagnostic Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Research Laboratories
• 5.3 Pharmaceutical Companies
• 5.4 Contract Research Organizations
• 5.5 Diagnostic Laboratories

6. Tissue Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Tissue Diagnostic Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Tissue Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Tissue Diagnostic Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Tissue Diagnostic Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Tissue Diagnostic Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Tissue Diagnostic Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Tissue Diagnostic Market Segmentation

• 9.1. Global Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Consumables, Antibodies, Kits, Reagents, Probes, Instruments, Slide Staining System, Scanner, Tissue Processing System
• 9.2. Global Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology And Workflow Management, Special Staining
• 9.3. Global Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC)
• 9.4. Global Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations
• 9.5. Global Tissue Diagnostic Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Biopsy Needles, Slides And Cover Slips, Tissue Embedding Materials
• 9.6. Global Tissue Diagnostic Market, Sub-Segmentation Of Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Primary Antibodies, Secondary Antibodies, Monoclonal Antibodies, Polyclonal Antibodies
• 9.7. Global Tissue Diagnostic Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diagnostic Kits, Assay Kits, Staining Kits
• 9.8. Global Tissue Diagnostic Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Fixatives, Staining Reagents, Antigen Retrieval Solutions
• 9.9. Global Tissue Diagnostic Market, Sub-Segmentation Of Probes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Fluorescent Probes, Molecular Probes, Hybridization Probes
• 9.10. Global Tissue Diagnostic Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Microscopes, Tissue Microarray Instruments, Laser Capture Microdissection Instruments
• 9.11. Global Tissue Diagnostic Market, Sub-Segmentation Of Slide Staining System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Automated Stainers, Manual Staining Systems
• 9.12. Global Tissue Diagnostic Market, Sub-Segmentation Of Scanner, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Digital Slide Scanners, Whole Slide Imaging Systems
• 9.13. Global Tissue Diagnostic Market, Sub-Segmentation Of Tissue Processing System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tissue Processors, Embedding Centers, Microtomes

10. Tissue Diagnostic Market Regional And Country Analysis

• 10.1. Global Tissue Diagnostic Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Tissue Diagnostic Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Tissue Diagnostic Market

• 11.1. Asia-Pacific Tissue Diagnostic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Tissue Diagnostic Market

• 12.1. China Tissue Diagnostic Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Tissue Diagnostic Market

• 13.1. India Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Tissue Diagnostic Market

• 14.1. Japan Tissue Diagnostic Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Tissue Diagnostic Market

• 15.1. Australia Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Tissue Diagnostic Market

• 16.1. Indonesia Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Tissue Diagnostic Market

• 17.1. South Korea Tissue Diagnostic Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Tissue Diagnostic Market

• 18.1. Taiwan Tissue Diagnostic Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Tissue Diagnostic Market

• 19.1. South East Asia Tissue Diagnostic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Tissue Diagnostic Market

• 20.1. Western Europe Tissue Diagnostic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Tissue Diagnostic Market

• 21.1. UK Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Tissue Diagnostic Market

• 22.1. Germany Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Tissue Diagnostic Market

• 23.1. France Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Tissue Diagnostic Market

• 24.1. Italy Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Tissue Diagnostic Market

• 25.1. Spain Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Tissue Diagnostic Market

• 26.1. Eastern Europe Tissue Diagnostic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Tissue Diagnostic Market

• 27.1. Russia Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Tissue Diagnostic Market

• 28.1. North America Tissue Diagnostic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Tissue Diagnostic Market

• 29.1. USA Tissue Diagnostic Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Tissue Diagnostic Market

• 30.1. Canada Tissue Diagnostic Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Tissue Diagnostic Market

• 31.1. South America Tissue Diagnostic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Tissue Diagnostic Market

• 32.1. Brazil Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Tissue Diagnostic Market

• 33.1. Middle East Tissue Diagnostic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Tissue Diagnostic Market

• 34.1. Africa Tissue Diagnostic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Tissue Diagnostic Market, Segmentation By Product, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Tissue Diagnostic Market Regulatory and Investment Landscape

36. Tissue Diagnostic Market Competitive Landscape And Company Profiles

• 36.1. Tissue Diagnostic Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Tissue Diagnostic Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Tissue Diagnostic Market Company Profiles
  • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Tissue Diagnostic Market Other Major And Innovative Companies

• Merck KGaA, BioGenex Laboratories, Sakura Finetek Co. Ltd., Philips Healthcare NV, Bio-Rad Laboratories, Ventana Medical Systems Inc., Hologic Inc., Becton Dickinson and Company, Sysmex Corporation, Cell Signaling Technology Inc., Enzo Life Sciences Inc., Leica Microsystems GmbH, Menarini Diagnostics S.r.l, PerkinElmer Inc., QIAGEN N.V.

38. Global Tissue Diagnostic Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Tissue Diagnostic Market

40. Tissue Diagnostic Market High Potential Countries, Segments and Strategies

• 40.1 Tissue Diagnostic Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Tissue Diagnostic Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Tissue Diagnostic Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer